
|Articles|January 13, 2020
Ergomed Acquires Ashfield Pharmacovigilance Inc.
Advertisement
Ergomed plc has announced the acquisition of Ashfield Pharmacovigilance Inc. from UDG Healthcare US Holdings, Inc. Ergomed has acquired the entire issued share capital of Ashfield PV for a total cash consideration of $10 million.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5






.png)



.png)



.png)
.png)
